Exploring the Complex Connection Between Diabetes and Cardiovascular Disease: Analyzing Approaches to Mitigate

Fnu Jyotsna1, Areeba Ahmed2, Kamal Kumar3

  • 1Medicine, Dr. B. R. Ambedkar Medical College & Hospital, Mohali, IND.

Cureus
|September 25, 2023
PubMed

Insights

Diabetes significantly increases cardiovascular disease (CVD) risk due to insulin resistance, hyperglycemia, and inflammation. Understanding these links is key to developing effective prevention and treatment strategies for diabetic patients.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Diseases

Background:

  • Cardiovascular disease (CVD) is the leading cause of death in diabetic patients.
  • Diabetes mellitus is strongly linked to increased cardiovascular morbidity and mortality.
  • Insulin resistance and hyperglycemia are central to the diabetes-CVD connection.

Purpose of the Study:

  • To review current evidence on preventing and treating cardiovascular complications in diabetes.
  • To synthesize literature on the mechanisms linking diabetes and CVD.
  • To identify strategies for mitigating cardiovascular risk in diabetic individuals.

Main Methods:

  • Comprehensive literature synthesis of recent evidence.
  • Narrative review of existing research.
  • Analysis of mechanisms including insulin resistance, dyslipidemia, oxidative stress, and inflammation.

Main Results:

  • Insulin resistance, hyperglycemia, oxidative stress, and inflammation exacerbate endothelial dysfunction and vascular damage.
  • Diabetes accelerates atherogenesis and atherosclerotic plaque rupture, increasing risks of myocardial infarction and stroke.
  • The interplay between diabetes and CVD significantly elevates the risk of cardiovascular events.

Conclusions:

  • A thorough understanding of the diabetes-CVD relationship is vital for effective patient management.
  • Evidence-based preventive measures and treatments can improve quality of life and reduce mortality in diabetic patients.
  • This review provides a foundation for developing innovative strategies to improve cardiovascular outcomes in diabetes.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
302
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11